A hair growth serum that uses plant derived extracellular vesicles and growth factors produced measurable gains in a small randomized, double blind trial, as reported by researchers led by Dr. Tsong Min Chang of Schweitzer Biotech Company. The study enrolled 60 adults in Taipei and asked participants to apply one milliliter nightly for eight weeks, with technicians measuring density, thickness, length, and shedding at four intervals.
The combination formula in the trial paired mild caffeine and panthenol with Centella asiatica vesicles, fibroblast growth factor 7, and insulin like growth factor 1, and produced about a 25 percent increase in hair thickness compared with placebo by the end of the eight week test, as reported by the study. The authors noted stepwise improvements across arms that stacked components, with the full mix showing the largest effect on density.
The study report also flagged limits and next steps, noting the trial involved healthy adults rather than diagnosed pattern hair loss, lasted eight weeks only, and relied in part on company employees and consultants, which raises routine questions about bias. The authors recommended independent replication, longer follow up, safety monitoring, and head to head comparisons with established therapies before moving claims beyond initial findings.
Market Claims Experts Advise Caution
Dermatologists and reviewers describe a crowded market of hair growth serum products that mix peptides, plant actives, oils, and proven drugs. Dr. Amin recommended ingredients such as rosemary oil, amla oil, caffeine, green tea, and coconut oil, while Dr. Lolis pointed to DHT blockers including saw palmetto and zinc as natural options to look for.
Coverage of consumer products highlights varied evidence. Glamour named Vegamour, The Ordinary Multi Peptide Serum, Cécred drops, and others as popular choices, and noted Rogaine 5 percent minoxidil remains the evidence based standard, a point several experts echoed. Allure noted most serums include non medicated ingredients and that randomized controlled trials are limited, while Dr. Lolis and Dr. Mian advised waiting about three months to judge effects.
On essential oils, Omer Ibrahim, MD, said rosemary shows promise with results similar to low concentration minoxidil, castor oil lacks strong clinical growth evidence, ginseng extract may help, and peppermint can boost circulation but irritate some scalps. At the same time, some brands make rapid improvement claims, such as Bare Anatomy advertising Redensyl and other actives and asserting large short term gains, a claim presented as product marketing rather than independent trial proof.
Observers across the coverage urged larger, longer trials and direct comparisons with minoxidil and finasteride, along with consistent product standardization and safety monitoring, before observers accept fast results as proven.
